J0888 Epoetin beta non esrd
Also known as: NeoRecormon, epoetin beta
Epoetin beta injection for patients without end-stage renal disease, an erythropoiesis-stimulating agent for treatment of chronic anemia.
In Plain Language
Medicine to increase red blood cells
Clinical Context
Used for treatment of anemia in cancer patients, patients with chronic kidney disease not yet requiring dialysis, or other chronic anemia conditions.
RVU Information
CPT J0888 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J0888?
CPT J0888 (Epoetin beta non esrd) is a J Codes (Drugs) code. Epoetin beta injection for patients without end-stage renal disease, an erythropoiesis-stimulating agent for treatment of chronic anemia.
How is J0888 administered?
CPT J0888 is administered by a healthcare provider, typically via injection or infusion. Used for treatment of anemia in cancer patients, patients with chronic kidney disease not yet requiring dialysis, or other chronic anemia conditions. It is used by Oncology, Nephrology, Internal Medicine.
When is CPT J0888 used?
Used for treatment of anemia in cancer patients, patients with chronic kidney disease not yet requiring dialysis, or other chronic anemia conditions.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.